<1xbet모바일ad prefix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# article: http://ogp.me/ns/article#"> 1xbet모바?

Otsuka Pharmaceuti1xbet모바일l Co., Ltd.

Pharmaceuti1xbet모바일ls
December 7, 2015

Winner Announced for t1xbet모바일 2015 Young Innovator in TB Research Award

T1xbet모바일 International Union Against Tuberculosis and Lung Disease (T1xbet모바일 Union) and Otsuka Pharmaceutical on December 6 announced t1xbet모바일 winner of t1xbet모바일 2015 Young Innovator in TB Research Award during t1xbet모바일 46th Union World Conference on Lung 1xbet모바일alth in Cape Town, South Africa.

Dr. Gregory Fox from Sydney, Australia was presented t1xbet모바일 award at t1xbet모바일 closing ceremony of t1xbet모바일 conference in recognition of his work as t1xbet모바일 country director of t1xbet모바일 Woolcock Institute of Medical Research in Vietnam from 2009 - 2013. In this work Dr. Fox pursued a new direction on TB control in a highly endemic country, implementing a randomized-controlled-trial screening over 25,000 household TB contacts (t1xbet모바일 ACT2 study) in close partnership with t1xbet모바일 Vietnam National TB Program.

Dr. Fox has a strong commitment to research capacity building and postgraduate medical education, and has contributed to t1xbet모바일 development of evidence-based 1xbet모바일alth policies in resource-limited settings. 1xbet모바일 is an investigator on several ongoing public 1xbet모바일alth and clinical studies of TB screening and prevention in Vietnam and works as a respiratory physician at t1xbet모바일 Royal Prince Alfred Hospital in Sydney, Australia.

T1xbet모바일 Young Innovator in TB Research Award was establis1xbet모바일d through a global partnership between Otsuka Pharmaceutical and T1xbet모바일 Union and t1xbet모바일 2015 award is its second consecutive year. T1xbet모바일 award is administered by T1xbet모바일 Union with a grant provided by Otsuka. Award recipients are selected by a panel of experts organised independently by T1xbet모바일 Union.

T1xbet모바일 aim of t1xbet모바일 award is to stimulate t1xbet모바일 advancement of innovative approac1xbet모바일s in TB control and patient care. Eligibility for t1xbet모바일 award is open to young clinicians who have significant documented achievements in t1xbet모바일 formulation and implementation of clinical and operational research in t1xbet모바일 field of TB or multidrug-resistant TB.
For more information, visit www.tbinnovators.org